dbo:abstract
|
- Aid Access is a nonprofit organization that provides access to medication abortion by mail to the United States and worldwide. It describes its work as a harm reduction strategy designed to provide safe access to mifepristone and misoprostol for people susceptible to pregnancy in the United States who may not otherwise have access to abortion or miscarriage management services. People are able to manage their own abortion with remote access to a physician and a help-desk for any questions. The website is available in English, Spanish, and Dutch. Aid Access was founded by Rebecca Gomperts, a Dutch physician, in March 2018. In 2019, Aid Access received a warning letter from the Food and Drug Administration (FDA) stating that they were not authorized to distribute generic mifeprestone in the US. Aid Access in turn sued the FDA, stating that they were helping women exercise their constitutional right to abortion. The FDA pursued no further legal action, and the lawsuit ended. Over subsequent years, the number of requests for their service has risen to average over 100 per day. In 2021, they started offering "advanced provision" pills, whereby someone can order the pills ahead of time in case they might need them in the future. (en)
- Aid Access est une société à responsabilité limitée qui fournit un accès à l'avortement médicamenteux en ligne et par courrier dans le monde entier. Elle a été fondée en décembre 2018 par Rebecca Gomperts, médecin néerlandaise. Son but est de réduire les risques sanitaires en fournissant un accès sûr à la mifepristone et au misoprostol à toute personne qui est en situation de grossesse non désirée de moins de dix semaines, et qui ne peut pas, ou peut difficilement, se tourner vers des cliniques d’interruption volontaire de grossesse ou de gestion des fausses couches. Les personnes sont en mesure d'autogérer leur propre avortement en contactant en ligne un médecin et un service d'assistance pour toute question. Le site web est disponible en anglais, espagnol et néerlandais. (fr)
|
dbo:foundedBy
| |
dbo:headquarter
| |
dbo:service
| |
dbo:thumbnail
| |
dbo:type
| |
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 19165 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:founder
| |
dbp:headquarters
| |
dbp:logo
|
- File:Aidaccesslogo.png (en)
|
dbp:name
| |
dbp:services
|
- Telemedicine prescription of medication abortion pills for delivery by mail (en)
|
dbp:type
|
- Nonprofit organization (en)
|
dbp:website
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
rdf:type
| |
rdfs:comment
|
- Aid Access is a nonprofit organization that provides access to medication abortion by mail to the United States and worldwide. It describes its work as a harm reduction strategy designed to provide safe access to mifepristone and misoprostol for people susceptible to pregnancy in the United States who may not otherwise have access to abortion or miscarriage management services. People are able to manage their own abortion with remote access to a physician and a help-desk for any questions. The website is available in English, Spanish, and Dutch. (en)
- Aid Access est une société à responsabilité limitée qui fournit un accès à l'avortement médicamenteux en ligne et par courrier dans le monde entier. Elle a été fondée en décembre 2018 par Rebecca Gomperts, médecin néerlandaise. (fr)
|
rdfs:label
|
- Aid Access (en)
- Aid Access (fr)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:homepage
| |
foaf:isPrimaryTopicOf
| |
foaf:name
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |